Korro Bio, Inc. (KRRO) vs Milestone Pharmaceuticals Inc. (MIST)

A side-by-side comparison of Korro Bio, Inc. and Milestone Pharmaceuticals Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — KRRO vs MIST

growth of $100 · dividends reinvested · last 7y
KRRO -98.5% (-45.4%/yr)MIST -95.9% (-36.6%/yr)MIST compounded faster over this window
0100200300400Start $100202120232025$1$4
KRRO MIST

KRRO vs MIST: by the numbers

  • •MIST is the larger company ($98M vs $97M market cap).
  • •Both run net losses; MIST's is the smaller (-3585.62% vs -4477.08% net margin).
  • •Both shrank revenue over the past five years; MIST's decline was smaller (-31.02% vs -41.67% CAGR).

Metrics side by side

Valuation

MetricKRROMIST
P/S ratio40.7841.66
P/B ratio0.945.36

Profitability

MetricKRROMIST
Gross margin33.04%94.58%
Operating margin-1366.43%-4041.72%
Net margin-4477.08%-3585.62%
ROE-103.31%-461.14%
ROIC-50.17%-49.27%

Growth (annualized)

MetricKRROMIST
Revenue CAGR (5Y)-41.67%-31.02%
Total return CAGR (5Y)-50.72%-33.18%

Frequently asked

Which has grown faster, KRRO or MIST?
Neither grew: over the past five years both shrank revenue, with MIST's decline the smaller — KRRO at a -41.67% CAGR versus MIST at -31.02%.
How have KRRO and MIST total returns compared?
Over the past 5 years, KRRO delivered -50.72% and MIST delivered -33.18% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.